BERKELEY, CA, Pivot Bio, a nitrogen innovator in agriculture, has closed a $430 million Series D funding led by DCVC and Temasek.
Pivot Bio, a nitrogen innovator in agriculture, has closed a $430 million Series D funding led by DCVC and Temasek, bringing the total equity raised to more than $600 million.
Generation Investment Management, G2 Venture Partners, and Rockefeller Capital Management joined the round along with Breakthrough Energy Ventures, Continental Grain Company, Prelude Ventures, Pavilion Capital, Bunge Ventures, Tekfen Ventures, and Roger Underwood.
Since the company introduced the industry's first commercially available microbial nitrogen in 2019, Pivot Bio has replaced synthetic nitrogen on more than 1 million crop acres in 2021 alone, representing more than 300% growth year-over-year and unprecedented agricultural product adoption.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about